Narcotics research, rehabilitation, and treatment. Hearings, Ninety ...
Narcotics research, rehabilitation, and treatment. Hearings, Ninety ... Narcotics research, rehabilitation, and treatment. Hearings, Ninety ...
,Chairman452Navy took and developed the best leads and they came up withsomethmg.Now, that is what I am talking about. The curiosity or openmindednesson the part of the Government, not you but the Government,that is out looking for a fellow with a good idea and wants to helphim develop it, see if it has got any potential, because we have notcome very far, we have not gotten beyond primitive yet in this field.So, that is the reason that we are perhaps embarrassing you bysuggesting that we would like to have you submit to us in response toour request an ideal budget if we were the Appropriations Committeeof the House of Representative and asked you, wdth your knowledgeof this problem and the gra^dty of it and the knowledge you have ofthe potentials in the field of research what would you offer as an idealbudget for NIMH.Would you be embarrassed to submit in response to our requestwhat you think in the national interest, if you were just asking forwhat you thought might wisely be used, an ideal budget for this field?Dr. Brown. It is within your prerogatives to ask for such a budgetand it is in our responsibilities to respond thoughtfully.Chairman Pepper. We would request you to do it and we do notwant you to feel any sense of embarrassemnt in doing it because weare authorized by the House of Representatives to explore this subjectto the fullest and we want to help the House by getting you to helpus with a recommendation.Would you consider that, Doctor, and submit to us what you thinkyou could wisely use?And like Franklin Delano Roosevelt, in thisDr. Brown. Yes, sir.problem we are all at sea, it is a stormy sea, and we need to get intothe deep waters of submarines to find new and creative answers.(For information concerning the budget discussed above, seematerial received for the record, p. 465.)Pepper. Mr. Rangel?/Mr. Rangel. Thank you, Mr. Chairman. I have a group that isinterested not only in the drug addiction problem, but also the survivalof communities, and if my colleagues would yield, I certainly wouldappreciate it. Thank you.Doctor, I suppose the Chair has indicated the general thrust ofthe feeling of this committee and in studying some of the otheractivities which your organization has taken on, it seems abimdantlyclear that the recent attack against narcotic addiction as declaredby the President has not yet reached the point that your institutionwould feel the vibrations, and I can understand your reluctance tocome before legislative bodies, especially being appointed by theExecutive, in making positive and affirmative requests for funding.However, in view of yovu- own admission of the primitive state ofaffairs that exists in the ai*ea of drug addiction, it seems to me thatmost of tliose who have testified before this committee have restrictedtheir concern to the methadone program, notwithstanding the factthat even the head of FDA, who you heartl testify this morning,declare*] that they have no jurisiliction over the activities of physiciansthat are misusing this drug and, in fact, creating methadone addictsin communities where the}'^ were not addicted Lo anything.
453In addition to that, there seems to be some rehictance on the partof all those who have testified from a variety of agencies to suggestthat the American Medical Association assume some of the responsibilityin this area, which allows me to believe that the politics thatare being considered involve the pharmaceutical houses, which againit has been testified, have not taken the leadership in terms of substitutivedrugs. Now, you have the prime responsibility in the areaof research and many of your j^rograms are methatlone related. Thereseems to be some contradiction between 3'our testimony and thatwhich was given earlier as to the economic and ethnic compositionof those who are being studied by your agency as opj^osed to thosegroups that allegedly are being studied, investigated, by the FDA.Dr. Brown. Yes. I was aware and sensitive to that issue as it cameout in your discussion.Mr. Rangel. What bothers me is that I think it is really unfair tothe American people to listen to witness after witness testif}^ as towhat aspects of research they are involved in. I thhik it is repugnantto the belief and credibility of any administration when a Presidentcan allege a war is going to be declared when we have before us todaya variety of agencies all of whom are now for the first time becominginvolved in research. We have the law^ enforcement agencies, we havethe Federal Bureau of Narcotics and Dangerous Drugs, we haveHUD, we have Model Cities, we have the Department of Defense asit relates to the militarv. Of course, vou have heard testimonv fromFDA.I do not know how many agencies are novv involved in some new,and some of them superficial, research areas. But I think what theChair was asking and what I am begging is, is your agency willingto assume the responsibility of having a centralized research centerfor the pur])oses of finding some cures to drug addiction?Dr. Brown. The answer to that is an unequivocal "Yes" and wewould hope that the Clinical Research Center at Lexington wouldmove in that direction and we are planning toward that. We havebeen moving toward having an adeqnate addiction research centerfor years and hopeful of achieving eminence and contributions inthis area.Mr. Rangel. But is it outside of your professional realm to suggestto this committee that you assume the responsibility with all ofthose that are now getting into research? I mean, how do you explainthat even though for 7 years a drug has been used in the UnitedStates of America, the FDA has not declared that this drug is safe?You have the prime responsibility to determine research in thisarea, and now State by State, city by city are asking for expansionof the program without lestrictions on the physician who is misusingthe drugs, and yet there is no word heard from your agency in termsof suggestions to the Department of Justice. One of my colleaguesasked would you recommend to the Department of Justice restriction,and he reluctantly said that he would not.Dr. Brown. You are asking terribly important and diflEicult questionsand I make it a practice not to be unresponsive but to try tobe honestly responsive. The reason for the situation is because theAvhole country has become aware of the seriousness of this problem.It is not only that each new agency is becoming involved but organizationafter organization from the American Legion to Women's Liber-
- Page 421 and 422: 401Now, because of our attention ha
- Page 423 and 424: 403and this is only for the investi
- Page 425 and 426: 405effects this drug will produce i
- Page 427 and 428: 407Now, if it is not used intravene
- Page 429 and 430: 409Mr. Wiggins. Dr. Jennings, does
- Page 431 and 432: 411Penicillin is good for pneumonia
- Page 433 and 434: 413Mr. R ANGEL. But from the studie
- Page 435 and 436: 415Dr. Gardner. Again, we don't hav
- Page 437 and 438: 417Dr. Edwards. I suspect it at lea
- Page 439 and 440: 419On the other hand, if serious si
- Page 441 and 442: 421of the best known programs. Alth
- Page 443 and 444: 423Medical Association, American Ps
- Page 445 and 446: 425of the United States Pharmacopei
- Page 447 and 448: 4275. Repeated examinations. Physic
- Page 449 and 450: 429agement and rehabilitation of se
- Page 451 and 452: —431As the agenc.v within HEW whi
- Page 453 and 454: 433and complex acts such as driving
- Page 455 and 456: 435(Inig induces physical and psych
- Page 457 and 458: 437Chiiirmtin Pepper. Doctor, I thi
- Page 459 and 460: 439A large proportion of youngsters
- Page 461 and 462: 441Dr. Brown, what would you say is
- Page 463 and 464: 443Chairmiui Pepper. Wliat is tlie
- Page 465 and 466: 446The state of the art is promisin
- Page 467 and 468: 447Lot nie ask you first, is tlic d
- Page 469 and 470: 449Chairman Pepper. Do you happen t
- Page 471: 451want you to take a look at. We w
- Page 475 and 476: 455the Mfldict is having a program
- Page 477 and 478: 457—on drugs? By that I mean, vei
- Page 479 and 480: 459\\ e are basically saying, in or
- Page 481 and 482: —;461that this is the extent to w
- Page 483 and 484: 463We could go into the drug area a
- Page 485 and 486: .465program that was i)ut into Jack
- Page 487 and 488: 467Mr. Brasco. Possibly. However, w
- Page 489 and 490: 469him, arrange to get somebody els
- Page 491 and 492: 471ainpheta.mines, or barbiturates.
- Page 493 and 494: 473In the meantime, the Institute d
- Page 495 and 496: 475treated in the community centers
- Page 497 and 498: 477research on narcotics in the sam
- Page 499 and 500: 479c 53 03E
- Page 501 and 502: NARCOTICS RESEARCH, REHABILITATION,
- Page 503 and 504: 483spending for research through NI
- Page 505 and 506: 485There has been no concerted seri
- Page 507 and 508: 487it is left in one of their veins
- Page 509 and 510: 489I do not think I should explain
- Page 511 and 512: 491Dr. ViLLARREAL. Until the reflex
- Page 513 and 514: 493evidence strongly shows is that
- Page 515 and 516: 495Chairman Pepper. One other quest
- Page 517 and 518: 497Dr. ViLLARREAL. So, it is a biol
- Page 519 and 520: '.499could result in a laboratory s
- Page 521 and 522: 5qifinds it in normal exploration.
453In addition to that, there seems to be some rehictance on the partof all those who have testified from a variety of agencies to suggestthat the American Medical Association assume some of the responsibilityin this area, which allows me to believe that the politics thatare being considered involve the pharmaceutical houses, which againit has been testified, have not taken the leadership in terms of substitutivedrugs. Now, you have the prime responsibility in the areaof <strong>research</strong> <strong>and</strong> many of your j^rograms are methatlone related. Thereseems to be some contradiction between 3'our testimony <strong>and</strong> thatwhich was given earlier as to the economic <strong>and</strong> ethnic compositionof those who are being studied by your agency as opj^osed to thosegroups that allegedly are being studied, investigated, by the FDA.Dr. Brown. Yes. I was aware <strong>and</strong> sensitive to that issue as it cameout in your discussion.Mr. Rangel. What bothers me is that I think it is really unfair tothe American people to listen to witness after witness testif}^ as towhat aspects of <strong>research</strong> they are involved in. I thhik it is repugnantto the belief <strong>and</strong> credibility of any administration when a Presidentcan allege a war is going to be declared when we have before us todaya variety of agencies all of whom are now for the first time becominginvolved in <strong>research</strong>. We have the law^ enforcement agencies, we havethe Federal Bureau of <strong>Narcotics</strong> <strong>and</strong> Dangerous Drugs, we haveHUD, we have Model Cities, we have the Department of Defense asit relates to the militarv. Of course, vou have heard testimonv fromFDA.I do not know how many agencies are novv involved in some new,<strong>and</strong> some of them superficial, <strong>research</strong> areas. But I think what theChair was asking <strong>and</strong> what I am begging is, is your agency willingto assume the responsibility of having a centralized <strong>research</strong> centerfor the pur])oses of finding some cures to drug addiction?Dr. Brown. The answer to that is an unequivocal "Yes" <strong>and</strong> wewould hope that the Clinical Research Center at Lexington wouldmove in that direction <strong>and</strong> we are planning toward that. We havebeen moving toward having an adeqnate addiction <strong>research</strong> centerfor years <strong>and</strong> hopeful of achieving eminence <strong>and</strong> contributions inthis area.Mr. Rangel. But is it outside of your professional realm to suggestto this committee that you assume the responsibility with all ofthose that are now getting into <strong>research</strong>? I mean, how do you explainthat even though for 7 years a drug has been used in the UnitedStates of America, the FDA has not declared that this drug is safe?You have the prime responsibility to determine <strong>research</strong> in thisarea, <strong>and</strong> now State by State, city by city are asking for expansionof the program without lestrictions on the physician who is misusingthe drugs, <strong>and</strong> yet there is no word heard from your agency in termsof suggestions to the Department of Justice. One of my colleaguesasked would you recommend to the Department of Justice restriction,<strong>and</strong> he reluctantly said that he would not.Dr. Brown. You are asking terribly important <strong>and</strong> diflEicult questions<strong>and</strong> I make it a practice not to be unresponsive but to try tobe honestly responsive. The reason for the situation is because theAvhole country has become aware of the seriousness of this problem.It is not only that each new agency is becoming involved but organizationafter organization from the American Legion to Women's Liber-
Change language